As we demonstrated in preclinical models,5 insulin and IGF-1 stimulated eNOS phosphorylation were blunted in SVEC from patients experiencing type 2 diabetes, compared with patients without type 2 diabetes (Figure 1E and 1G). The gene discussed is IGF1; the disease is type 2 diabetes mellitus.